Sedation with dexmedetomidine hydrochloride during endoscopic submucosal dissection of gastric cancer

Digestive Endoscopy

Volumn 23, Issue 2, 2011, Pages 176-181

  Takimoto, Kengo ^a   Ueda, Tomohiro ^a   Shimamoto, Fukutaro ^a   Kojima, Yusuke ^a   Fujinaga, Yosuke ^a   Kashiwa, Atufumi ^a   Yamauchi, Hiroaki ^a   Matsuyama, Kiichi ^a   Toyonaga, Takashi ^b   Yoshikawa, Toshikazu ^c  

^a TAKEDA GENERAL HOSPITAL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c KOBE UNIVERSITY HOSPITAL   (Japan)

Author keywords

dexmedetomidine hydrochloride; endoscopic submucosal dissection (ESD); gastric tumor; sedation

Indexed keywords

DEXMEDETOMIDINE; MIDAZOLAM; PROPOFOL;

ADULT; AGED; ARTICLE; BODY MOVEMENT; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; ENDOSCOPIC SUBMUCOSAL DISSECTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN SATURATION; RANDOMIZED CONTROLLED TRIAL; SEDATION; SINGLE BLIND PROCEDURE; STOMACH CANCER;

ADENOCARCINOMA; ADENOMA; AGED; AGED, 80 AND OVER; AROUSAL; CONSCIOUS SEDATION; DEXMEDETOMIDINE; DISSECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GASTRIC MUCOSA; GASTROSCOPY; HUMANS; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; MALE; MIDAZOLAM; MIDDLE AGED; NEOPLASM STAGING; PROPOFOL; PROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 79953040350     PISSN: 09155635     EISSN: 14431661     Source Type: Journal    
DOI: 10.1111/j.1443-1661.2010.01080.x     Document Type: Article

References (24)

1. Ostermann ME, Keenan SP, Seiferling RA, Sibbald WJ,. Sedation in the intensive care unit: A systematic review. JAMA 2000; 283: 1451-9. (Pubitemid 30151824)
2. Shapiro BA, Warren J, Egol AB, et al,. Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: An executive summary. Crit. Care Med. 1995; 23: 1596-600.
3. Carrasco G, Molina R, Costa J, Soler JM, Cabre L,. Propofol versus midazolam in short-, medium-, and long-term sedation of critically ill patients. A cost-benefit analysis. Chest 1993; 103: 557-64. (Pubitemid 23070763)
4. Searle NR, Sahab P,. Propofol in patients with cardiac disease. Can. J. Anaesth. 1993; 40: 730-47. (Pubitemid 23278494)
5. Bennett SN, McNeil MM, Bland LA, et al,. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N. Engl. J. Med. 1995; 333: 147-54.
6. Kang TM,. Propofol infusion syndrome in critically ill patients. Ann. Pharmacother. 2002; 36: 1453-6. (Pubitemid 34925283)
7. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ,. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth. Analg. 2000; 90: 699-705. (Pubitemid 30117535)
8. Belleville JP, Ward DS, Bloor BC, Maze M,. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology 1992; 77: 1125-33. (Pubitemid 23001123)
9. Venn RM, Hell J, Grounds RM,. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit. Care. 2000; 4: 302-8.
10. Hsu YW, Cortinez LI, Robertson KM, et al,. Dexmedetomidine pharmacodynamics: Part1: Crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology 2004; 101: 1066-76. (Pubitemid 39430785)
11. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD,. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000; 93: 382-94. (Pubitemid 30620311)
12. Scheinin H, Jaakola ML, Sjovall S, et al,. Intramuscular dexmedetomidine as premedication for general anesthesia. A comparative multicenter study. Anesthesiology 1993; 78: 1065-75. (Pubitemid 23174232)
13. Bauer TM, Ritz R, Haberthur C, et al,. Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet 1995; 346: 145-7.
14. Martin E, Ramsay G, Mantz J, Sum-Ping ST,. The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J. Intensive Care Med. 2003; 18: 29-41. (Pubitemid 44526587)
15. Venn RM, Bradshaw CJ, Spencer R, et al,. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999; 54: 1136-42.
16. Ramsay MA, Savege TM, Sympson BR, Goodwin R,. Controlled sedation with alphaxalone-alphadolone. Br. Med. J. 1974; 2: 656-9.
17. Correa-Sales C, Rabin BC, Maze M,. A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats. Anesthesiology 1992; 76: 948-52.
18. Lakhlani PP, MacMillan LB, Guo TZ, et al,. Substitution of a mutant alpha2a-adrenergic receptor via 'hit and run' gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proc. Natl Acad. Sci. U. S. A. 1997; 94: 9950-5.
19. Nelson LE, Lu J, Guo T, Saper CB, Franks NP, Maze M,. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology 2003; 98: 428-36. (Pubitemid 36592812)
20. Kamibayashi T, Maze M,. Clinical use of alpha2-adrenergic agonists. Anesthesiology 2000; 93: 1345-9.
21. Riker RR, Shehabi Y, Bokesch PM, et al,. Dexmedetomidine vs midazolam for sedation of critically ill patients: A randomized trial. JAMA 2009; 301: 489-99.
22. Link RE, Desai K, Hein L, et al,. Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. Science 1996; 273: 803-5. (Pubitemid 26271527)
23. Hashiguchi K, Matsunaga H, Higuchi H, Miura S,. Dexmedetomidine for sedation during upper gastrointestinal endoscopy. Dig. Endosc. 2008; 20: 178-83.
24. Kaneko E, Harada H, Kasugai T, Ogoshi K, Niwa H,. The 4th report of gastrointestinal endoscopic incidents in Japan from 1998 to 2002. Gastroenterol. Endosc. 2004; 46: 54-61. (translated by author).